NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,976,000 | -83.3% | 244,924 | -53.0% | 0.07% | -79.8% |
Q4 2021 | $17,778,000 | +11.4% | 521,041 | +57.5% | 0.37% | +20.8% |
Q3 2021 | $15,961,000 | -8.5% | 330,872 | -14.3% | 0.30% | -6.8% |
Q2 2021 | $17,444,000 | +0.7% | 386,187 | +7.5% | 0.32% | -11.4% |
Q1 2021 | $17,327,000 | -30.3% | 359,256 | -22.2% | 0.37% | -34.2% |
Q4 2020 | $24,860,000 | +18.5% | 461,740 | -18.8% | 0.56% | -21.6% |
Q3 2020 | $20,985,000 | +8.1% | 568,857 | -9.2% | 0.71% | +1.4% |
Q2 2020 | $19,416,000 | +14.1% | 626,719 | +1.7% | 0.70% | -23.4% |
Q1 2020 | $17,010,000 | -40.7% | 616,086 | -37.2% | 0.92% | -30.7% |
Q4 2019 | $28,704,000 | +52.4% | 981,348 | -0.4% | 1.32% | +27.4% |
Q3 2019 | $18,837,000 | -8.5% | 985,218 | +5.0% | 1.04% | +2.0% |
Q2 2019 | $20,577,000 | +1.2% | 937,862 | -5.6% | 1.02% | -6.9% |
Q1 2019 | $20,335,000 | +35.4% | 993,904 | -16.5% | 1.09% | +2.7% |
Q4 2018 | $15,015,000 | -21.6% | 1,190,698 | -4.5% | 1.06% | +2.3% |
Q3 2018 | $19,146,000 | +20.4% | 1,247,327 | +2.8% | 1.04% | +8.5% |
Q2 2018 | $15,903,000 | +74.6% | 1,213,014 | +8.7% | 0.96% | +45.6% |
Q1 2018 | $9,106,000 | -6.7% | 1,115,974 | +1.3% | 0.66% | -14.3% |
Q4 2017 | $9,761,000 | -17.7% | 1,101,653 | +3.4% | 0.77% | -22.3% |
Q3 2017 | $11,854,000 | +30.8% | 1,065,082 | +5.3% | 0.99% | +18.4% |
Q2 2017 | $9,060,000 | -12.2% | 1,011,124 | -22.7% | 0.84% | -19.4% |
Q1 2017 | $10,319,000 | -48.7% | 1,307,879 | -44.3% | 1.04% | +49.9% |
Q4 2016 | $20,106,000 | +19.8% | 2,346,105 | +14.9% | 0.69% | +25.6% |
Q3 2016 | $16,789,000 | +4.3% | 2,042,505 | +2.0% | 0.55% | -6.3% |
Q2 2016 | $16,103,000 | +34.1% | 2,002,805 | +12.4% | 0.59% | +34.3% |
Q1 2016 | $12,005,000 | -17.1% | 1,781,135 | -3.3% | 0.44% | -12.2% |
Q4 2015 | $14,488,000 | +38.9% | 1,840,975 | +1.1% | 0.50% | +54.2% |
Q3 2015 | $10,433,000 | -0.6% | 1,820,717 | -6.2% | 0.32% | +8.8% |
Q2 2015 | $10,500,000 | +83.5% | 1,940,929 | +58.4% | 0.30% | +81.1% |
Q1 2015 | $5,721,000 | +8.1% | 1,224,979 | -3.5% | 0.16% | +6.5% |
Q4 2014 | $5,291,000 | -24.0% | 1,268,806 | -5.1% | 0.15% | -28.4% |
Q3 2014 | $6,966,000 | +64.4% | 1,337,115 | +4.8% | 0.22% | +73.4% |
Q2 2014 | $4,236,000 | -3.7% | 1,275,893 | +0.6% | 0.12% | +4.2% |
Q1 2014 | $4,399,000 | +17.8% | 1,267,661 | +22.9% | 0.12% | +24.0% |
Q4 2013 | $3,733,000 | +219.6% | 1,031,131 | +164.9% | 0.10% | +209.7% |
Q3 2013 | $1,168,000 | +21.3% | 389,230 | +60.9% | 0.03% | +10.7% |
Q2 2013 | $963,000 | – | 241,950 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |